DNBSEQ-T7 by Complete Genomics (MGI Tech): status and timeline

Milestones

No announced next step

DNBSEQ-T7 in production2024Complete.

Spec sheet

Spec	DNBSEQ-T7
Data per 24-hour run	6-7 Terabases^R (reported)

^R reported by the company

About Complete Genomics (MGI Tech)

The team behind DNBSEQ-T7

Complete Genomics (MGI Tech)

DNBSEQ-T7+ sequencer, high-throughput sequencing, $100 genome

Complete Genomics, headquartered in San Jose and owned by MGI Tech (China), builds high-throughput sequencing. DNBSEQ-T7+ (Feb 2026) sequences 144 human genomes in 24 hours at ~$100 each. US available after FDA clearance.

Complete Genomics pioneered whole-genome sequencing; MGI now owns and scales it.
T7+ (Feb 2026): 144 human genomes in 24 hours at ~$100 per genome.
US available Feb 2026, competing directly with Illumina NovaSeq.

completegenomics.com (opens completegenomics.com)Company profile →

Founded: 200620 yrs
Headquarters: United States
Status: Private
Valuation: private
Staff: ~421Dec 2025
Works in: BiotechGenomics & sequencing
Coverage: 2 programs · 1 updatelatest 1 Feb 2026checked 11 Oct
Acquired by: MGI Tech (opens mgitech.com)